BENACORT® Nasal Spray – 24hr Hay Fever Relief – Alcohol Free – Fragrance Free – Budesonide Nasal Spray – 60 Sprays, 10ml

Product Information

If at any time you would like to opt out from marketing, you can visit the Privacy Preferences page and select the relevant options. Budesonide undergoes an extensive degree (~90%) of biotransformation on first passage by CYP3A4 enzymes to metabolites of low glucocorticosteroid activity.

This is of limited clinical importance for short-term (1-2 weeks) treatment with itraconazole or ketoconazole or other potent CYP3A inhibitors, but should be taken into consideration during long-term treatment. It helps ease symptoms of hay fever by reversing these effects, improving the swelling and reducing mucus production.

Before combining medications, however, you should always consult your healthcare provider or chemist to avoid potential interactions or adverse effects. The symptoms that accompany a cold are usually a thick watery yellow discharge from the nose, the body will ache and you’ll have a low grade fever. Hay fever is usually worse between late March and September, especially when it’s warm, humid, and windy. Adverse drug reactions (ADRs) identified during clinical trials and post-marketing experience with budesonide are listed below by System Organ Class (SOC). Do not use: - continuously for more than one month without consulting your doctor - in children and adolescents under 18 years.

Benacort Nasal Spray is a highly effective steroidal nasal spray for individuals over the age of 18 to prevent and control hay fever-related sneezing, nasal congestion, and an itchy, runny nose. The interaction is of limited clinical importance for short-term (1-2 weeks) treatment with itraconazole or ketoconazole or other potent CYP3A inhibitors but should be taken into consideration during long-term treatment. Benacort Nasal Spray should be kept at room temperature and out of direct heat, moisture, and sunlight. you have tuberculosis (TB) a chest infection, chicken pox or measles or have been in contact with somebody who has TB, chicken pox or measles.

At the recommended dosage, BENADRYL ® products do not cause drowsiness in the majority of sufferers. At therapeutic doses of this medicine no effects on the breast-fed infant are anticipated since maternal systemic exposure after intranasal administration is low, so minimal exposure to intranasal budesonide in breast-fed infants is expected. of the daily maternal dose for both dose levels, and the average plasma concentration in infants was estimated to be 1/600th of the concentrations observed in maternal plasma, assuming complete infant oral bioavailability. It can take up to a couple of days before the full effects of Benacort Nasal Spray can be felt, but with regular use, the relief this medicine offers is significant and long-lasting. When possible, we always recommend to start the treatment of seasonal rhinitis before exposure to the allergens.